1. Home
  2. ISTR vs AKBA Comparison

ISTR vs AKBA Comparison

Compare ISTR & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$28.54

Market Cap

394.5M

Sector

Finance

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.01

Market Cap

375.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISTR
AKBA
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.5M
375.0M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
ISTR
AKBA
Price
$28.54
$1.01
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$31.50
$4.67
AVG Volume (30 Days)
126.1K
5.0M
Earning Date
04-20-2026
05-07-2026
Dividend Yield
1.59%
N/A
EPS Growth
4.41
93.94
EPS
0.77
N/A
Revenue
N/A
N/A
Revenue This Year
$66.56
N/A
Revenue Next Year
$5.18
N/A
P/E Ratio
$37.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.89
$0.88
52 Week High
$30.49
$4.08

Technical Indicators

Market Signals
Indicator
ISTR
AKBA
Relative Strength Index (RSI) 56.01 34.96
Support Level $26.18 N/A
Resistance Level $28.84 $1.56
Average True Range (ATR) 0.50 0.08
MACD 0.06 -0.03
Stochastic Oscillator 72.19 19.55

Price Performance

Historical Comparison
ISTR
AKBA

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: